Documents A to Z

ALL | | 1 | 2 | 3 | 4 | 5 | 7 | 8 | 9 | A | B | C | D | E | F | G | H | I | J | L | M | N | O | P | Q | R | S | T | U | V | W | Z

Notes on the design of bioequivalence study: nitrofurantoin PDF

Guideline/guidance

Notes on the design of bioequivalence study: nitrofurantoin PDF

Guideline/guidance

Notes on the design of bioequivalence study: norethisterone PDF

Guideline/guidance

Notes on the design of bioequivalence study: norethisterone enanthate PDF

Guideline/guidance

Notes on the design of bioequivalence study: norethisterone enanthate/estradiol valerate PDF

Guideline/guidance

Notes on the design of bioequivalence study: norgestrel PDF

Guideline/guidance

Notes on the design of bioequivalence study: norgestrel PDF

Guideline/guidance

Notes on the design of bioequivalence study: oseltamivir PDF

Guideline/guidance

Notes on the design of bioequivalence study: para-aminosalicylic acid PDF

Guideline/guidance

Notes on the design of bioequivalence study: praziquantel PDF

Guideline/guidance

Notes on the design of bioequivalence study: pretomanid PDF

Guideline/guidance

Notes on the design of bioequivalence study: Primaquine PDF

Notes on the design of bioequivalence study: procaine benzylpenicillin PDF

Guideline/guidance

Notes on the design of bioequivalence study: progesterone vaginal ring PDF

Guideline/guidance

Notes on the Design of Bioequivalence Study: Pyrazinamide (6 February 2024) PDF

Guideline/guidance

Notes on the Design of Bioequivalence Study: Pyridoxine (6 February 2024) PDF

Guideline/guidance

Notes on the design of bioequivalence study: pyrimethamine PDF

Guideline/guidance

Notes on the design of bioequivalence study: pyrimethamine/sulfadoxine PDF

Guideline/guidance

Notes on the design of bioequivalence study: raltegravir PDF

Guideline/guidance

Notes on the design of bioequivalence study: remdesivir PDF

Guideline/guidance

Notes on the design of bioequivalence study: ribavirin PDF

Guideline/guidance

Notes on the design of bioequivalence study: rifabutin (8 May 2025) PDF

Guideline/guidance

Notes on the design of bioequivalence study: rifampicin (10 May 2025) PDF

Guideline/guidance

Notes on the design of bioequivalence study: rifampicin/clarithromycin PDF

Guideline/guidance

Notes on the design of bioequivalence study: rifapentine PDF

Guideline/guidance

Notes on the design of bioequivalence study: ritonavir PDF

Guideline/guidance

Notes on the design of bioequivalence study: sofosbuvir PDF

Guideline/guidance

Notes on the design of bioequivalence study: sofosbuvir/daclatasvir PDF

Guideline/guidance

Notes on the design of bioequivalence study: sofosbuvir/ledipasvir PDF

Guideline/guidance

Notes on the design of bioequivalence study: sofosbuvir/velpatasvir PDF

Guideline/guidance

Notes on the design of bioequivalence study: sulfadiazine PDF

Guideline/guidance

Notes on the design of bioequivalence study: Sulfamethoxazole/Trimethoprim PDF

Guideline/guidance

Notes on the design of bioequivalence study: tafenoquine PDF

Guideline/guidance

Notes on the design of bioequivalence study: tenofovir disoproxil fumarate PDF

Guideline/guidance

Notes on the design of bioequivalence study: terizidone PDF

Guideline/guidance

Notes on the design of bioequivalence study: ulipristal acetate PDF

Guideline/guidance

Notes on the design of bioequivalence study: velpatasvir PDF

Guideline/guidance

Notes on the design of bioequivalence study: zanamivir PDF

Guideline/guidance

Notes on the design of bioequivalence study: zidovudine PDF

Guideline/guidance

Notes on the design of bioequivelence study: benzathine benzylpenicillin PDF

Guideline/guidance

Notes on the design of bioequivelence study: emtricitabine/tenofovir/efavirenz PDF

Guideline/guidance

Notes on the design of bioequivelence study: ethambutol/isoniazid (16 January 2018) PDF

Guideline/guidance

Notes on the design of bioequivelence study: ethambutol/isoniazid/pyrazinamide/rifampicin PDF

Guideline/guidance

Notes on the design of bioequivelence study: ethambutol/isoniazid/rifampicin PDF

Guideline/guidance

Notes on the design of bioequivelence study: isoniazid/pyrazinamide/rifampicin PDF

Guideline/guidance

Notes on the design of bioequivelence study: isoniazid/rifampicin PDF

Guideline/guidance

Notes on the design of bioequivelence study: isoniazid/rifapentine PDF

Guideline/guidance

Notes on the design of bioequivelence study: lamivudine/tenofovir/efavirenz PDF

Guideline/guidance

Notes on the design of bioequivelence study: miltefosine PDF

Guideline/guidance

Notes on the design of bioequivelence study: raltegravir PDF

Guideline/guidance